Virtual Screening Yields a Potent New MAPKAPK2 Inhibitor Against Pancreatic Cancer
Researchers used structure-based virtual screening of roughly 280,000 compounds to discover compound 77501, a novel and selective MAPKAPK2 inhibitor that ...
Researchers used structure-based virtual screening of roughly 280,000 compounds to discover compound 77501, a novel and selective MAPKAPK2 inhibitor that ...
An adaptive artificial intelligence framework slashes the computational cost of screening billion-molecule chemical libraries while experimentally confirming high-quality ligand hits ...
Insilico Medicine has nominated ISM9077, an artificial intelligence-designed inhibitor of an undisclosed “Target Y,” as a preclinical candidate for dry ...
Jacksonville, Fla. — Mayo Clinic researchers have used artificial intelligence to identify an experimental small-molecule drug that targets a protein ...
In a groundbreaking study published in Nature Chemical Biology, researchers have unveiled the molecular mechanisms by which tubulin variants and ...
In the relentless quest to accelerate drug discovery and reduce astronomical costs, researchers are increasingly turning to machine learning to ...
In a significant breakthrough that harnesses the cutting-edge capabilities of artificial intelligence (AI) in drug discovery, Insilico Medicine, a leading ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine